Targeting Mutant-p53 for Cancer Treatment: Are We There Yet?
Lim DV, Woo WH, Lim JX, Loh XY, Soh HT, Lim SYA, Lee ZY, Yow HY, Hamzah SB, Sellappans R, Foo JB.
Lim DV, et al. Among authors: yow hy.
Curr Mol Pharmacol. 2024;17(1):e140923221042. doi: 10.2174/1874467217666230914090621.
Curr Mol Pharmacol. 2024.
PMID: 37711005
Review.